This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Antiplatelet therapy in primary care - primary prevention of cardiovascular disease (CVD)

Authoring team

Antiplatelet therapy in primary care with respect to primary prevention of cardiovascular disease:

  • low-dose aspirin (75mg daily) should be considered for all patients over the age of 50 at high risk of coronary heart disease (CHD) (10-year CHD risk of 15% or more) provided hypertension is controlled
  • clopidogrel and MR-dipyridamole are not indicated or licensed for primary prevention of CV events

Reference:

  1. MeReC Bulletin 2005; 15(6):21-4.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.